Cargando…
Subcutaneous pyelovesical bypass – Detour bypass – as a solution for ureteric obstruction
INTRODUCTION: Many patients suffer from unilateral or bilateral hydronephroses caused by pelvic tumors, retroperitoneal fibrosis, occlusion due to radiation therapy or iatrogenic damage to the ureter. Currently, percutaneous nephrostomy or double J stents are primarily used. Nephrostomy deteriorates...
Autores principales: | Wrona, Andrzej Jerzy, Zgajewski, Jarosław, Kopeć, Norbert, Chodor, Dominik, Kopcza, Paweł, Klekot, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791398/ https://www.ncbi.nlm.nih.gov/pubmed/29410898 http://dx.doi.org/10.5173/ceju.2017.1397 |
Ejemplares similares
-
Nephron sparing surgery for metastatic collecting duct carcinoma
por: Kopeć, Norbert, et al.
Publicado: (2019) -
Subcutaneous nephrovesical bypass: Treatment for ureteral obstruction in advanced metastatic disease
por: WANG, YUNYAN, et al.
Publicado: (2015) -
Subcutaneous ureteral bypass device placement in 81 cats with benign ureteral obstruction (2013‐2018)
por: Wuillemin, Florian, et al.
Publicado: (2021) -
Therapeutic use of tetrasodium ethylenediaminetetraacetic acid solution for treatment of subcutaneous ureteral bypass device mineralization in cats
por: Chik, Colin, et al.
Publicado: (2019) -
Use of tetrasodium EDTA acid for the treatment of intraluminal obstruction of subcutaneous ureteral bypass devices
por: Duval, Valerie, et al.
Publicado: (2022)